10 Pharmaceutical Stocks to Buy Now According to Billionaire Kerr Neilson
In this article, we will look at 10 pharmaceutical stocks to buy now according to billionaire Kerr Neilson.
Syneos Health Inc. (SYNH)
Get Email AlertsHedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Cardinal Capital Amy Minella | 934,806 | $75,673 | +1% | 1.91% |
| 2. | Lakewood Capital Management Anthony Bozza | 478,000 | $38,694 | -9% | 1.95% |
| 3. | Magnetar Capital Alec Litowitz And Ross Laser | 287,055 | $23,237 | +814% | 0.24% |
| 4. | Sectoral Asset Management Jerome Pfund And Michael Sjostrom | 176,306 | $14,272 | +8% | 2.53% |
| 5. | Brant Point Investment Management Ira Unschuld | 107,980 | $8,741 | +7% | 0.99% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $59.11 | 8,691 | Director | 17,426 | 2020-07-06 | Filing | |
| $36.65 | 1,300 | Officer | 26,855 | 2020-03-19 | Filing | |
| $36.00 | 45 | Officer | 63,829 | 2020-03-20 | Filing | |
| $36.75 | 3,510 | Officer | 63,784 | 2020-03-20 | Filing | |
| $41.27 | 750 | Officer | 11,314 | 2018-12-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $90.00 | 1,055 | Officer | 6,685 | 2022-01-31 | Filing | |
| $103.00 | 93 | Officer | 8,738 | 2021-12-30 | Filing | |
| $100.95 | 1,889 | Officer | 20,775 | 2021-12-23 | Filing | |
| $99.00 | 93 | Officer | 8,831 | 2021-12-22 | Filing | |
| $97.02 | 4,122 | Director | 5,167 | 2021-12-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 217,957 | $17,643,620 | 0% | |
| 2. | 11,527,780 | $933,174 | 0.02% | |
| 3. | 9,724,346 | $787,185 | 0.01% | |
| 4. | 9,430,935 | $763,434 | 0.13% | |
| 5. | 8,640 | $699,000 | 0.27% |
News See All
Did Hedge Funds Get Syneos Health, Inc. (SYNH) Right?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Should I Buy Syneos Health, Inc. (SYNH)?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious...
Hedge Funds Are Crazy About Syneos Health, Inc. (SYNH
We at Insider Monkey have gone over 873 13F filings that hedge funds and prominent investors are required to file by the SEC.
15 Best Mid-Cap Stocks for 2021
Mid-cap stocks are considered in the middle of small-cap and large-cap stocks. While mid-cap (i.e.
Hedge Funds Are Selling Syneos Health, Inc. (SYNH)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is SYNH Stock A Buy or Sell?
The Insider Monkey team has completed processing the quarterly 13F filings for the December quarter submitted by the hedge funds and other money managers included in our extensive database.
Hedge Funds Have Never Been This Bullish On Syneos Health, Inc. (SYNH)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Did Hedge Funds Make The Right Call On Syneos Health, Inc. (SYNH) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Billionaire Hedge Funds
